Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-010798
Filing Date
2025-04-16
Accepted
2025-04-16 16:06:51
Documents
1
Period of Report
2025-04-07

Document Format Files

Seq Description Document Type Size
1 form4-04162025_080447.html 4  
1 form4-04162025_080447.xml 4 6609
  Complete submission text file 0001415889-25-010798.txt   8051
Mailing Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462
Business Address 630 W GERMANTOWN PIKE SUITE 215 PLYMOUTH MEETING PA 19462 (484) 539-9800
Harmony Biosciences Holdings, Inc. (Issuer) CIK: 0001802665 (see all company filings)

EIN.: 822279923 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 8105 NORTH MERRILL STREET NILES IL 60714
Business Address
Zaeske Adam H. (Reporting) CIK: 0002064712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39450 | Film No.: 25842916